Pictor Unveils High-Resolution Protein Analysis Platform at ADLM 2026
The research-use-only platform combines imaging, software, and multiplex protein analysis into a standard 96-well workflow designed to simplify biomarker research.
The research-use-only platform combines imaging, software, and multiplex protein analysis into a standard 96-well workflow designed to simplify biomarker research.
Anthem Blue Cross and Blue Shield will cover C2N Diagnostics’ PrecivityAD2 blood test for Alzheimer’s disease evaluation starting Oct 1, 2026, expanding access to the diagnostic tool for adults with cognitive decline.
A pilot program with American Oncology Network allows clinicians to order molecular tests and receive results within their existing workflow.
The expanded commercialization agreement aims to increase availability of the GlycoKnow Ovarian laboratory-developed test through Aranscia’s clinical workflow and technology platforms.
Read MoreThe patent covers a gene-expression profiling method designed to identify patients most likely to respond to the investigational therapy stenoparib through 2042.
Read MoreHerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read MoreCNSide Diagnostics has secured a national agreement with Elevance Health, expanding access to its CSF Tumor Cell Enumeration assay to 45.4 million more people in the US, Plus Therapeutics announced.
Read MoreGRAIL secured $110 million in equity financing from Samsung affiliates to support U.S. regulatory efforts and expand its Galleri multi-cancer early detection test into Asian markets, the companies announced.
Read MoreThe agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read MoreTecan has integrated agentic AI, powered by NVIDIA’s BioNeMo Agent Toolkit, into its Introspect laboratory analytics platform to enable proactive operations and improve productivity in clinical labs.
Read MoreThe approval allows Quest Diagnostics to offer its minimal residual disease test for patients in all 50 states.
Read MoreThe CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.
Read MoreAgilent Technologies has partnered with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in lab workflows, aiming to deliver faster scientific insights and advance intelligent instruments, software, and services.
Read MoreThe updated test includes additional DPYD variants recommended by the Association for Molecular Pathology to help identify patients who may be at risk for severe chemotherapy side effects.
Read MoreThe initiative aims to standardize digital pathology through an open-source platform and image management system.
Read MoreDiazyme Laboratories has acquired Carolina Liquid Chemistries, integrating CLC’s chemistry systems and reagents with Diazyme’s diagnostic technologies to expand solutions for reference and clinical laboratories.
Read MoreThe integrated electrophoresis solution is designed to simplify routine verification by eliminating gel casting and buffer preparation.
Read MoreThe Callisto Sample Prep System application is optimized for the PromethION platform to support whole genome sequencing workflows.
Read More